SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 20 Nov 2018